Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
John G Logan
Affiliation
Imperial College London
ORCID
Career Start Year
2007
Papers
28
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
33473114
Accelerating functional gene discovery in osteoarthritis.
Nat Commun
2021
33798441
Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption.
Cell
2021
33636130
Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption.
Cell
2021
33473114
Accelerating functional gene discovery in osteoarthritis.
Nat Commun
2021
33953184
Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease.
Nat Commun
2021
34050183
Publisher Correction: Accelerating functional gene discovery in osteoarthritis.
Nat Commun
2021
33636130
Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption.
Cell
2021
33798441
Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption.
Cell
2021
33953184
Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease.
Nat Commun
2021
34050183
Publisher Correction: Accelerating functional gene discovery in osteoarthritis.
Nat Commun
2021
32553114
A trans-eQTL network regulates osteoclast multinucleation and bone mass.
Elife
2020
33370286
Mouse mutant phenotyping at scale reveals novel genes controlling bone mineral density.
PLoS Genet
2020
32553114
A trans-eQTL network regulates osteoclast multinucleation and bone mass.
Elife
2020
33370286
Mouse mutant phenotyping at scale reveals novel genes controlling bone mineral density.
PLoS Genet
2020
30929064
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo.
Calcif Tissue Int
2019
30929064
Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo.
Calcif Tissue Int
2019
30760120
Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha.
Thyroid
2019
30729486
Quantitative X-Ray Imaging of Mouse Bone by Faxitron.
Methods Mol Biol
2019
30721528
Slc20a2, Encoding the Phosphate Transporter PiT2, Is an Important Genetic Determinant of Bone Quality and Strength.
J Bone Miner Res
2019
31306808
PYY is a negative regulator of bone mass and strength.
Bone
2019
31306808
PYY is a negative regulator of bone mass and strength.
Bone
2019
30729486
Quantitative X-Ray Imaging of Mouse Bone by Faxitron.
Methods Mol Biol
2019
30760120
Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha.
Thyroid
2019
30721528
Slc20a2, Encoding the Phosphate Transporter PiT2, Is an Important Genetic Determinant of Bone Quality and Strength.
J Bone Miner Res
2019
29304378
Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects.
Am J Hum Genet
2018
29304378
Life-Course Genome-wide Association Study Meta-analysis of Total Body BMD and Assessment of Age-Specific Effects.
Am J Hum Genet
2018
29662632
Regulation of breast cancer induced bone disease by cancer-specific IKKβ.
Oncotarget
2018
29662632
Regulation of breast cancer induced bone disease by cancer-specific IKKβ.
Oncotarget
2018
28869591
Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis.
Nat Genet
2017
28965856
Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
Cancer Lett
2017
28869591
Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis.
Nat Genet
2017
29229863
Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo.
Proc Natl Acad Sci U S A
2017
28965856
Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
Cancer Lett
2017
29229863
Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo.
Proc Natl Acad Sci U S A
2017
27535945
Rapid phenotyping of knockout mice to identify genetic determinants of bone strength.
J Endocrinol
2016
27535945
Rapid phenotyping of knockout mice to identify genetic determinants of bone strength.
J Endocrinol
2016
26018249
Thyrostimulin Regulates Osteoblastic Bone Formation During Early Skeletal Development.
Endocrinology
2015
26018249
Thyrostimulin Regulates Osteoblastic Bone Formation During Early Skeletal Development.
Endocrinology
2015
26195631
Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis.
J Biol Chem
2015
26195631
Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis.
J Biol Chem
2015
24480136
THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women.
Eur J Endocrinol
2014
24480136
THRA and DIO2 mutations are unlikely to be a common cause of increased bone mineral density in euthyroid post-menopausal women.
Eur J Endocrinol
2014
25228983
Generation and culture of osteoclasts.
Bonekey Rep
2014
24792211
Quantitative X-ray microradiography for high-throughput phenotyping of osteoarthritis in mice.
Osteoarthritis Cartilage
2014
25228983
Generation and culture of osteoclasts.
Bonekey Rep
2014
24792211
Quantitative X-ray microradiography for high-throughput phenotyping of osteoarthritis in mice.
Osteoarthritis Cartilage
2014
23239200
Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis.
J Bone Miner Res
2013
23239200
Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis.
J Bone Miner Res
2013
21955294
Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.
Br J Pharmacol
2012
22593270
Mice lacking the calcineurin inhibitor Rcan2 have an isolated defect of osteoblast function.
Endocrinology
2012
1 - 50 of 56
Column Actions
Search
Recommended Authors
Jianhua Luo
University of Pittsburgh
Career Start Year
2015
Number of shared co-authors
0
Danielle L Brown
WIL Research Laboratories
Career Start Year
2013
Number of shared co-authors
0
Kit Man Tsang
and Blood Institute, National Institutes of Health
Career Start Year
2008
Number of shared co-authors
0
Ian Welch
University of British Columbiagrid.17091.3e
Career Start Year
2008
Number of shared co-authors
0
Hui Fang
Beihua University
Career Start Year
2007
Number of shared co-authors
1
Jin Zhang
Shandong University
Career Start Year
2007
Number of shared co-authors
0
Jake Chen
Tufts University School of Dental Medicine
Career Start Year
2003
Number of shared co-authors
0
Charles R Farber
University of Virginia
Career Start Year
2003
Number of shared co-authors
17
Shunsuke Uehara
Matsumoto Dental University
Career Start Year
2002
Number of shared co-authors
0
Claus-Eric Ott
Charite-Universitatsmedizin Berlin
Career Start Year
2002
Number of shared co-authors
0
Jiliang Li
Indiana University Purdue University Indianapolis
Career Start Year
2001
Number of shared co-authors
0
Qisheng Tu
Tufts University School of Dental Medicine
Career Start Year
2001
Number of shared co-authors
0
Fernando Lecanda
University of Navarra, Center for Applied Medical Research
Career Start Year
1995
Number of shared co-authors
2
Fiona Ginty
GE Global Research Center
Career Start Year
1994
Number of shared co-authors
0
Mingyao Liu
The Institute of Biomedical Sciences, East China Normal University
Career Start Year
1994
Number of shared co-authors
0
Tadahiro Iimura
Hokkaido University
Career Start Year
1994
Number of shared co-authors
0
Beom-Jun Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
1993
Number of shared co-authors
1
Kurt D Hankenson
University of Michigan School of Medicine ann arbor
Career Start Year
1991
Number of shared co-authors
3
Cun-Yu Wang
University of California, Los Angeles (university of california los angeles)
Career Start Year
1991
Number of shared co-authors
0
Ralph A Zirngibl
University of Toronto
Career Start Year
1990
Number of shared co-authors
2
Teresa L Johnson-Pais
University of Texas Health San Antonio
Career Start Year
1990
Number of shared co-authors
0
Clifford J Rosen
Maine Medical Center Research Institute
Career Start Year
1989
Number of shared co-authors
7
Adrienne M Flanagan
University College London, UCL Cancer Institute
Career Start Year
1987
Number of shared co-authors
3
Fran??oise R??dini
Nantes Universite, Inserm UMR 7, CNRS UMR 6075, Universite d'Angers
Career Start Year
1986
Number of shared co-authors
1
Nancy E Lane
Center for Musculoskeletal Health, University of California Davis School of Medicine
Career Start Year
1982
Number of shared co-authors
12
Mary C Farach-Carson
The University of Texas Health Science Center at Houston School of Dentistry
Career Start Year
1981
Number of shared co-authors
1
Lynda F Bonewald
Indiana Center for Musculoskeletal Health, Indiana University School of Medicine
Career Start Year
1977
Number of shared co-authors
10
Jane E Aubin
University of Toronto
Career Start Year
1975
Number of shared co-authors
2
Jane B Lian
University of Vermont
Career Start Year
1973
Number of shared co-authors
2
Robert F Klein
Southern Plains Agricultural Research Center, USDA-ARS, College Station
Career Start Year
1960
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Graham R Williams
Imperial College London Hammersmith Hospital London UK.
Co-authored papers
16
John P Kemp
Co-authored papers
5
Jacqueline K White
Wellcome Trust Sanger Institute
Co-authored papers
4
David J Adams
Wellcome Sanger Institute
Co-authored papers
4
David M Evans
Medical Research Council Integrative Epidemiology Unit at the University of Bristol
Co-authored papers
3
Eleftheria Zeggini
Co-authored papers
3
John Brent Richards
Lady Davis Institute for Medical Research, Jewish General Hospital
Co-authored papers
3
Fernando Rivadeneira
University Medical Center Rotterdam
Co-authored papers
3
Lorraine Southam
Co-authored papers
2
Vincenzo Forgetta
5 Prime Sciences Inc.
Co-authored papers
2
John A Morris
Co-authored papers
2
Jon H Tobias
Co-authored papers
2
Sheue-Yann Cheng
National Cancer Institute, National Institutes of Health
Co-authored papers
2
Helmut Fuchs
Institute of Experimental Genetics, German Mouse Clinic
Co-authored papers
2
Martin Hrab?? de Angelis
German Center for Diabetes Research (DZD e.V.)
Co-authored papers
2
Valerie Gailus-Durner
Institute of Experimental Genetics, German Mouse Clinic
Co-authored papers
2
Jan Rozman
German Center for Diabetes Research (DZD)
Co-authored papers
2
Juan Gallegos
Baylor College of Medicine
Co-authored papers
1
Ann-Marie Mallon
The Turing Institute
Co-authored papers
1
Martin den Heijer
Co-authored papers
1
Corey L Reynolds
Baylor College of Medicine
Co-authored papers
1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
1
Karen L Svenson
Co-authored papers
1
Babette S Zemel
Children's Hospital of Philadelphia
Co-authored papers
1
Timo A Lakka
Co-authored papers
1
Robert A Scott
Co-authored papers
1
Tamara B Harris
National Institute on Aging
Co-authored papers
1
Douglas P Kiel
Hinda and Arthur Marcus Institute for Aging Research
Co-authored papers
1
Stephen A Murray
Columbia University.
Co-authored papers
1
Nicholas J Wareham
Co-authored papers
1
1 - 30